Evolution and future directions of bispecific antibodies in breast cancer: a global clinical trial landscape analysis

To the Editor,Breast cancer remains the most frequently diagnosed malignancy in women worldwide, with over 2.3 million new cases annually [1]. Despite the success of endocrine therapies, chemothera...

Authors

Yiheng Li (ORCID: https://orcid.org/0009-0002-8148-3050)
Xubin Zhu
Shiyou Luo

Institutions

Longgang Central Hospital (CN)

Publication Details

Journal: Future Science OA
Published: 2026-07-16
DOI: https://doi.org/10.1080/20565623.2026.2703784
Primary Topic: Monoclonal and Polyclonal Antibodies Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Evolution and future directions of bispecific antibodies in breast cancer: a global clinical trial landscape analysis

Yiheng Li, Xubin Zhu, Shiyou Luo

Jul 16, 2026

Future Science OA

Monoclonal and Polyclonal Antibodies Research

article

Evolution and future directions of bispecific antibodies in breast cancer: a global clinical trial landscape analysis

Yiheng Li, Xubin Zhu, Shiyou Luo

July 16, 2026article en

Abstract

Future Science OAVol. 12(1)

Longgang Central Hospital (CN)

Good health and well-being

Openalex Percentile: Top 9%

Monoclonal and Polyclonal Antibodies Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.